BioCardia BCDA
NASDAQ BCDA
$0.95 -0.03 (-3.27%)
As of: Oct 22, 2026 · 12:39 PM EDT

BioCardia (BCDA) Preferred Shares (2015)

Updated

BioCardia (BCDA) recorded Preferred Shares of $46.03 million in Q4 2015.

Analysis

BioCardia (BCDA) Preferred Shares (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,166.97 Bn 1,135.56 Bn 19.71 Bn -
2 Johnson & Johnson 644.38 Bn 564.24 Bn 17.30 Bn -
3 AbbVie 501.54 Bn 474.65 Bn 12.70 Bn -
4 Merck 359.36 Bn 313.74 Bn 12.21 Bn -
5 Novartis Ag 302.13 Bn 266.12 Bn 11.24 Bn -
6 Astrazeneca 267.59 Bn 241.28 Bn 12.86 Bn -
7 Amgen 241.49 Bn 196.89 Bn 7.24 Bn -
8 Gilead Sciences 192.85 Bn 167.05 Bn 6.22 Bn -
9 Pfizer 171.77 Bn 118.41 Bn 10.94 Bn -
10 BioCardia 11.49 Mn -1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 46.03 Mn
API Access

BioCardia Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=BCDA&period=max&api_key=YOUR_API_KEY